Skip to content
★ Sign in to follow
UA

Umari Abdul-Wahab

Executive
Idera Pharmaceuticals, Inc.
Total declarations
15
Company
1
▲ Purchases (4 ops.)
—
▼ Sales (3 ops.)
—

Latest filing published 23 May 2014 for Idera Pharmaceuticals, INC..

Insider track record

Disclosed buys
4
Disclosed sells
3
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Umari Abdul-Wahab: trading record in brief

This profile gathers the share dealings of Umari Abdul-Wahab in Idera Pharmaceuticals, Inc. We count 15 filings; the first trade dates from 1 April 2013 and the latest from 23 May 2014.

Both buying and selling appear: 4 purchases, against 3 sales. The totals do not cover 7 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 8 share grants. Since January 2014: no purchases and 3 sales on the market.

The newest entry dates from 23 May 2014: an open-market sale, in Idera Pharmaceuticals, Inc. The clock since the last published purchase (2 October 2013) now reads 4,786 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Umari Abdul-Wahab

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations